Table 3
Provincial or Regional SARS-CoV-2 antibody seroprevalence estimates, by antibody seroprevalence type
| Antibody seroprevalence overall percentage | Low 95% Confidence Interval | High 95% Confidence Interva | Antibody seroprevalence due to infection percentage | Low 95% Confidence Interval | High 95% Confidence Interval | Antibody seroprevalence due to vaccination percentage | Low 95% Confidence Interval | High 95% Confidence Interval | |
|---|---|---|---|---|---|---|---|---|---|
| Canada | 3.6 | 2.6 | 4.2 | 2.6 | 1.6 | 3.2 | 1.0 | 0.0 | 1.3 |
| Atlantic Region | 1.3 | 0.3 | 1.8 | 0.5 | 0.0 | 0.7 | 0.9 | 0.0 | 1.3 |
| Quebec | 4.4 | 3.2 | 5.4 | 3.2 | 2.1 | 4.1 | 1.2 | 0.2 | 1.7 |
| Ontario | 3.3 | 1.6 | 5.5 | 2.5 | 1.1 | 4.4 | 0.8 | 0.0 | 1.9 |
| Manitoba | 3.1 | 1.8 | 4.5 | 2.4 | 1.2 | 3.6 | 0.7 | 0.0 | 1.5 |
| Saskatchewan | 4.1 | 2.6 | 5.7 | 2.9 | 1.6 | 4.3 | 1.2 | 0.1 | 2.2 |
| Alberta | 5.6 | 4.0 | 7.4 | 4.0 | 2.6 | 5.7 | 1.6 | 0.3 | 3.4 |
| British Columbia | 2.4 | 1.1 | 3.9 | 1.6 | 0.5 | 2.9 | 0.8 | 0.0 | 1.7 |
| Territories Region | 21.1 | 17.6 | 25.0 | 0.0 | 0.0 | 0.8 | 21.1 | 17.6 | 25.0 |
Note(s):
Some seroprevalence estimates may not add correctly due to rounding.
Source(s):
Statistics Canada; Canadian COVID-19 Antibody and Health Survey (5339).
- Date modified: